July 2018

7:00 PM Keynote Address IV Shannon Hall  Oral Talk #96 Repetitive Structures Produce Highly Immunogenic Vaccines Against Papillomaviruses, Polyomaviruses, and Epstein-Barr Virus Douglas Lowy1 1National Cancer Institute  1. Virus infection and human cancer: an overviewSchiller JT, Lowy DR.Recent Results Cancer Res. 2014;193:1-10. doi: 10.1007/978-3-642-38965-8_1.PMID: 240082902. Vaccines to prevent infections by oncoviruses.Schiller JT, Lowy DR.Annu Rev Microbiol. 2010;64:23-41. doi: […]

Session Chairs: Hongyu Deng (a “She”) and Cliona Rooney Oral Talk #90 The KSHV Protein ORF68 is a Proteasome-Manipulating Nuclease Required for DNA Packaging Matthew Gardner1, Stephanie Gates1, Andreas Martin1, Britt Glaunsinger1 1The University of California Berkeley Six viral proteins are required for DNA packaging into nascent herpesviral capsids and for HSV, the majority of

Session 10A 11:00 AM – 12:30 PM Immunity & Immune Therapy (Shannon Hall)Session Chairs: Dirk Dittmer & Rajiv Khanna Oral Talk #84 A Role for EBNA2 in Mechanisms that Foster Some Autoimmune Diseases John B. Harley1,2,3,4,5, Xiaoting Chen1, Mario Pujato1, Daniel Miller1, Avery Maddox1, Carmy Forney1, Albert F. Magnusen1, Arthur Lynch1, Kashish Chetal6, Masashi Yukawa7,

Session Chairs: Thomas Schulz (replaced by a lady) and Micah Luftig Oral Talk #78 Increased Association between EBV EBNA2 from Type 2 Strains and the Transcriptional Repressor BS69 Restricts B Cell Growth Rajesh Ponnusamy1, Ritika Khatri1, Paolo Correia2, Erika Mancini1, Paul J. Farrell2, Michelle J. West11School of Life Sciences, University of Sussex,, 2Section of Virology,

Session Chairs: Britt Glaunsinger and Yasuaki Harabuchi (下屆EBV會議主辦人) (Play Circle) Oral Talk #70 Role of KSHV in T cell Infiltration in Kaposi’s Sarcoma Microenvironment Canrong Zhong1, Nannan Zhu1, Yuqing Li1, Yan Yuan1,2 1Sun Yat-sen University, 2University of Pennsylvania Kaposi’s sarcoma-associated herpesvirus (KSHV), also termed human herpesvirus type 8 (HHV8), is an etiologic agent of Kaposi’s Sarcoma

Session 8A Latency 10:30 AM – 12:00 PMSession Chairs: Jennifer Totonchy & Maria Masucci EBV Persistence without its EBNA3A and 3C Oncogenes in vivo Anita Murer Oral Talk #62 EBV Persistence without its EBNA3A and 3C Oncogenes in vivo Anita Murer1, Donal McHugh1, Nicole Caduff1, Jens Kalchschmidt2, Mario Barros3, Andrea Zbinden4, Riccarda Capaul4, Gerald Niedobitek3,

Session Chairs: Scott Tibbetts & Erik Flemington Oral Talk #54 Misprocessing of Cellular Noncoding RNAs as a Pathway for Cell-Intrinsic Immune Activation Yang Zhao1, Xiang Ye1, William Dunker1, Yu Song1, John Karijolich1 1Vanderbilt University School of Medicine The RIG-I like receptors (RLRs) RIG-I and MDA5 are cytosolic RNA helicases best characterized as restriction factors for

Session Chairs: Denise Whitby & Christian Münz Oral Talk #50 Malaria as a Risk Factor for Early Age of KSHV Infection in a Cohort of Children in Western Kenya Rosemary Rochford1, Katherine Sabourin1, Ibrahim Daud3, Peter O. Sumba3, Nazzarrena Labo2, Wendell Miley2, Denise Whitby21University of Colorado, 2Frederick National Laboratory for Cancer Research, 3Kenya Medical Research

1:00 PM Keynote Address III Bettina Kempkes Bettina Kempkes studied biology and graduated from the Albert-LudwigUniversity Freiburg in 1986. She received her PhD at the Max-PlanckInstitute of Immunobiology in Freiburg for her work on the T cell receptorrepertoire of hapten-specific T cells in 1989. Between 1989 and 1994 sheworked as a postdoctoral research fellow at

Session Chairs: Charles Wood & Alan Chiang  (Play Circle)Newly Derived endemic Burkitt Lymphoma Cell Lines from Kenyan Patients and the Makings of an Avatar Mouse Model Ann M. Moormann Oral Talk #43 Newly Derived Endemic Burkitt Lymphoma Cell Lines from Kenyan Patients and the Makings of an Avatar Mouse Model Ann M. Moormann1, Priya Saikumar